Tasocitinib Citrate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tasocitinib Citrate
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Tasocitinib Citrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 29 USDMF, 1 JDMF, 10 EU WC, 22 KDMF, 28 NDC API, 54 Listed Suppliers, $ API Reference Price

72 API Suppliers
29 USDMF
1 JDMF
10 EU WC
22 KDMF
28 NDC API
54 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

INTERMEDIATES

58 Intermediate Suppliers

58 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

72 FDF Dossiers, 22 FDA Orange Book, 4 Europe, 9 Canada, 17 Australia, 1 South Africa, 19 Listed Dossiers

72 FDF Dossiers
22 FDA Orange Book
4 Europe
9 Canada
17 Australia
1 South Africa
19 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 3 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 5 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 19 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

1 Rochem International Inc
3 SPI Pharma
3 DKSH
3 Faran Shimi Pharmaceutical
2 Boai NKY Pharmaceuticals Ltd
5 Gangwal Healthcare
4 Nanjing Well Pharmaceutical
1 Alcedo Pharmachem
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
4 BASF
5 DFE Pharma
1 Finar
4 Gangwal Chemicals
1 Huzhou Sunflower Pharmaceutical
1 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
17 Kerry
10 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
19 Roquette
1 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
10 Sigachi Industries
1 Valens Pharmachem
3 Vasa Pharmachem
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 18 Film Formers & Plasticizers, 17 Direct Compression, 13 Disintegrants & Superdisintegrants, 12 Granulation, 11 Coating Systems & Additives, 10 Lubricants & Glidants, 10 Thickeners and Stabilizers, 8 Co-Processed Excipients, 8 Taste Masking, 5 Parenteral, 4 Chewable & Orodispersible Aids, 4 Solubilizers, 4 Topical, 4 Controlled & Modified Release, 3 Coloring Agents, 2 Rheology Modifiers, 2 Emulsifying Agents, 1 Soft Gelatin

48 Fillers, Diluents & Binders
18 Film Formers & Plasticizers
17 Direct Compression
13 Disintegrants & Superdisintegrants
12 Granulation
11 Coating Systems & Additives
10 Lubricants & Glidants
10 Thickeners and Stabilizers
8 Co-Processed Excipients
8 Taste Masking
5 Parenteral
4 Chewable & Orodispersible Aids
4 Solubilizers
4 Topical
4 Controlled & Modified Release
3 Coloring Agents
2 Rheology Modifiers
2 Emulsifying Agents
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 196 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
196 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
2 Finished Drug Prices
10 Annual Reports

MARKET PLACE

21 APIs, 2 FDF Dossiers

21 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

15 US Patents, 3 US Exclusivities, 3 Health Canada Patents

15 US Patents
3 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

24 Others

24 Others

$ API Ref.Price (USD/KG) : 13,876 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Pfizer Canada ULC

filter Patent Reset all filters

3 All

01 12393640

02 12448281

03 12469350

filter Product Reset all filters

3 All

01 3TOFACITINIB CITRATE

filter Dosage Reset all filters

3 All

01 3TABLET

filter Exp Date Reset all filters

3 All

01 12020-11-23

02 12022-05-29

03 12022-11-25

Minakem Tofacitinib Citrate

Product Main Page

01

Pfizer Canada ULC

Tofacitinib Citrate

BioAsia

Not Confirmed

Pfizer Canada ULC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-11-25

Date Granted : 2009-09-29

Tofacitinib Citrate

Brand Name : XELJANZ

Patent Number : 2469350

Filing Date : 2002-11-25

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-11-25

Date Granted : 2009-09-29

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada ULC

Tofacitinib Citrate

BioAsia

Not Confirmed

Pfizer Canada ULC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-05-29

Date Granted : 2009-05-05

Tofacitinib Citrate

Brand Name : XELJANZ

Patent Number : 2448281

Filing Date : 2002-05-29

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-05-29

Date Granted : 2009-05-05

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada ULC

Tofacitinib Citrate

BioAsia

Not Confirmed

Pfizer Canada ULC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-11-23

Date Granted : 2006-09-05

Tofacitinib Citrate

Brand Name : XELJANZ

Patent Number : 2393640

Filing Date : 2000-11-23

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-11-23

Date Granted : 2006-09-05

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!